The global biosimilars market is estimated to be valued at US$ 29.4 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: The biosimilars market offers lower cost alternative to expensive biologic drugs. This lower cost allows more patients...
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian